Atricure Inc. buy UBS Group AG
Start price
29.09.23
/
50%
€37.20
Target price
29.09.24
€52.82
Performance (%)
-
End price
30.09.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 10.714% | 10.714% | -40.000% |
| iShares Core DAX® | 0,44 % | 5,64 % | 7,81 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % | 27,24 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % | 49,27 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 22,34 % |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $56.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten

